Literature DB >> 27442856

Pulmonary Hypertension in the Era of Mechanical Circulatory Support.

Yamini Krishnamurthy1, Lauren B Cooper, Kishan S Parikh, G Michael Felker, Carmelo A Milano, Joseph G Rogers, Adrian F Hernandez, Chetan B Patel.   

Abstract

Left heart disease (LHD) represents the most common cause of pulmonary hypertension (PH), and is associated with worse prognosis compared with LHD without PH. In addition, PH due to LHD may prevent patients from receiving heart transplantation, because of risk of perioperative right ventricular failure. Current literature lacks comprehensive descriptions and management strategies of PH due to LHD. In this review, we summarize the literature that is available to highlight the definition, pathogenesis, and prognosis of PH due to LHD. Furthermore, we discuss the use of mechanical circulatory support (MCS) in this population. Finally, we provide recommendations regarding the management and reassessment of PH due to LHD in the specific context of MCS.

Entities:  

Mesh：

Year:  2016        PMID： 27442856      PMCID： PMC5001897          DOI： 10.1097/MAT.0000000000000408

Source DB:  PubMed          Journal:  ASAIO J        ISSN： 1058-2916            Impact factor:   2.872


  52 in total

1.  Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.

Authors:  Taimoor Hashim; Kumar Sanam; Marina Revilla-Martinez; Charity J Morgan; Jose A Tallaj; Salpy V Pamboukian; Renzo Y Loyaga-Rendon; James F George; Deepak Acharya
Journal:  Circ Heart Fail       Date:  2015-07-15       Impact factor: 8.790

2.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

3.  Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management.

Authors:  D L Moraes; W S Colucci; M M Givertz
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

4.  The effects of debanding on the lung expression of ET-1, eNOS, and cGMP in rats with left ventricular pressure overload.

Authors:  Shah-Hwa Chou; Chee-Yin Chai; Jiunn-Ren Wu; Mian-Shin Tan; Chaw-Chi Chiu; Ing-Jun Chen; Acro Y Jeng; Chung-I Chang; Aij-Lie Kwan; Zen-Kong Dai
Journal:  Exp Biol Med (Maywood)       Date:  2006-06

5.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

6.  Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system support.

Authors:  N G Smedira; M G Massad; J Navia; R L Vargo; A N Patel; D J Cook; P M McCarthy
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

7.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Observations from non-invasive measures of right heart hemodynamics in left ventricular assist device patients.

Authors:  Kaitlyn My-Tu Lam; Stephanie Ennis; Gerry O'Driscoll; Jorge M Solis; Thomas Macgillivray; Michael H Picard
Journal:  J Am Soc Echocardiogr       Date:  2009-07-31       Impact factor: 5.251

10.  PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.

Authors:  Ryan J Tedford; Anna R Hemnes; Stuart D Russell; Ilan S Wittstein; Mobusher Mahmud; Ari L Zaiman; Stephen C Mathai; David R Thiemann; Paul M Hassoun; Reda E Girgis; Jonathan B Orens; Ashish S Shah; David Yuh; John V Conte; Hunter C Champion
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790
View more
  1 in total

Review 1.  Exercise physiology in left ventricular assist device patients: insights from hemodynamic simulations.

Authors:  Libera Fresiello; Christoph Gross; Steven Jacobs
Journal:  Ann Cardiothorac Surg       Date:  2021-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.